(NASDAQ: AGEN) Agenus's forecast annual revenue growth rate of 22.58% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Agenus's revenue in 2024 is $156,314,000.On average, 4 Wall Street analysts forecast AGEN's revenue for 2024 to be $5,767,691,661, with the lowest AGEN revenue forecast at $2,844,467,343, and the highest AGEN revenue forecast at $13,183,414,918. On average, 4 Wall Street analysts forecast AGEN's revenue for 2025 to be $3,913,279,089, with the lowest AGEN revenue forecast at $3,024,602,978, and the highest AGEN revenue forecast at $5,267,920,006.
In 2026, AGEN is forecast to generate $6,030,815,364 in revenue, with the lowest revenue forecast at $3,673,929,102 and the highest revenue forecast at $8,636,037,449.